Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH)

CUSIP: 03209R103

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock
Shares outstanding
46,377,939
Total 13F shares
35,330,537
Share change
+795,178
Total reported value
$1,713,563,419
Put/Call ratio
30%
Price per share
$48.53
Number of holders
276
Value change
+$41,888,246
Number of buys
134
Number of sells
127

Quarterly Holders Quick Answers

What is CUSIP 03209R103?
CUSIP 03209R103 identifies AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
13%
5,942,524
$237,700,960 30 Jun 2024
13F
VANGUARD GROUP INC
13F
Company
5.8%
2,672,862
$106,914,480 30 Jun 2024
13F
FEDERATED HERMES, INC.
13F
Company
4.2%
1,944,800
$77,792,000 30 Jun 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
3.6%
1,691,569
$67,662,760 30 Jun 2024
13F
Neuberger Berman Group LLC
13F
Company
3.5%
1,622,609
$64,904,360 30 Jun 2024
13F
Mary Z. Luo
3/4/5
COO,Chief Scientist & Chairman, Director, 10%+ Owner
class O/S missing
1,109,416
$63,239,930 10 Jan 2024
STATE STREET CORP
13F
Company
3.3%
1,529,536
$61,181,440 30 Jun 2024
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
2.7%
1,272,818
$50,912,718 30 Jun 2024
13F
Epoch Investment Partners, Inc.
13F
Company
2.3%
1,078,852
$43,154,080 30 Jun 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
2.3%
1,070,275
$42,811,000 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2%
906,348
$36,261,207 30 Jun 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
1.6%
740,408
$29,616,320 30 Jun 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.6%
738,748
$29,549,920 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
1.3%
610,137
$24,405,480 30 Jun 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.3%
583,906
$23,357,000 30 Jun 2024
13F
NORTHERN TRUST CORP
13F
Company
1.2%
564,123
$22,564,920 30 Jun 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.2%
537,700
$21,508,000 30 Jun 2024
13F
BOONE CAPITAL MANAGEMENT LLC
13F
Company
1.1%
495,089
$19,803,560 30 Jun 2024
13F
BESSEMER GROUP INC
13F
Company
1%
466,228
$18,649,000 30 Jun 2024
13F
Invesco Ltd.
13F
Company
0.97%
450,930
$18,037,200 30 Jun 2024
13F
Granite Investment Partners, LLC
13F
Company
0.86%
397,514
$15,900,560 30 Jun 2024
13F
Richard Koo
3/4/5
Director
mixed-class rows
286,471
mixed-class rows
$15,350,254 07 Jun 2021
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.77%
359,222
$14,368,880 30 Jun 2024
13F
Mesirow Institutional Investment Management, Inc.
13F
Company
0.76%
353,447
$14,137,880 30 Jun 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.65%
301,589
$12,063,560 30 Jun 2024
13F
Bank of New York Mellon Corp
13F
Company
0.63%
289,954
$11,598,160 30 Jun 2024
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.6%
280,584
$11,335,594 30 Jun 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.57%
263,151
$10,526,040 30 Jun 2024
13F
Point72 Asset Management, L.P.
13F
Company
0.51%
235,836
$9,433,440 30 Jun 2024
13F
MARSHALL WACE, LLP
13F
Company
0.49%
227,127
$9,085,080 30 Jun 2024
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.47%
218,172
$8,726,880 30 Jun 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.44%
206,219
$8,248,760 30 Jun 2024
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.43%
201,473
$8,058,920 30 Jun 2024
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.42%
197,001
$7,880,040 30 Jun 2024
13F
Assenagon Asset Management S.A.
13F
Company
0.41%
189,605
$7,584,200 30 Jun 2024
13F
SILVERCREST ASSET MANAGEMENT GROUP LLC
13F
Company
0.37%
169,576
$6,783,040 30 Jun 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.34%
156,264
$6,250,476 30 Jun 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.33%
155,267
$6,210,680 30 Jun 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.33%
153,606
$6,144,240 30 Jun 2024
13F
OBERWEIS ASSET MANAGEMENT INC/
13F
Company
0.29%
135,055
$5,402,200 30 Jun 2024
13F
LAM GROUP, INC.
13F
Company
0.28%
130,800
$5,232,000 30 Jun 2024
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
0.27%
124,768
$4,990,726 30 Jun 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.27%
123,913
$4,956,520 30 Jun 2024
13F
UBS Group AG
13F
Company
0.26%
122,681
$4,907,240 30 Jun 2024
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.25%
114,719
$4,588,760 30 Jun 2024
13F
Portolan Capital Management, LLC
13F
Company
0.23%
108,863
$4,354,520 30 Jun 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.23%
106,100
$4,244,000 30 Jun 2024
13F
Legal & General Group Plc
13F
Company
0.23%
105,849
$4,233,960 30 Jun 2024
13F
Trexquant Investment LP
13F
Company
0.23%
105,745
$4,229,800 30 Jun 2024
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.22%
104,121
$4,164,840 30 Jun 2024
13F

Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q3 2024

As of 30 Sep 2024, Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by 276 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,330,537 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, TD Asset Management Inc, FEDERATED HERMES, INC., NEUBERGER BERMAN GROUP LLC, STATE STREET CORP, FULLER & THALER ASSET MANAGEMENT, INC., Epoch Investment Partners, Inc., DIMENSIONAL FUND ADVISORS LP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 278 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
268
Q3 2024 holders
276
Holder diff
8
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .